Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Other Non-Current Liabilities (2024 - 2025)

Century Therapeutics (IPSC) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 57.0% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, down 57.0% year-over-year, with the annual reading at $3.8 million for FY2025, 57.0% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $3.8 million at Century Therapeutics, up from $784000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $9.0 million in Q3 2024, with the low at $20000.0 in Q1 2024.